Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Fuji
Farmers Insurance
UBS
US Department of Justice
Medtronic
AstraZeneca
Teva
Cantor Fitzgerald

Generated: November 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020639

« Back to Dashboard

NDA 020639 describes SEROQUEL, which is a drug marketed by Astrazeneca Pharms and Astrazeneca and is included in two NDAs. It is available from six suppliers. Additional details are available on the SEROQUEL profile page.

The generic ingredient in SEROQUEL is quetiapine fumarate. There are fifty-three drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the quetiapine fumarate profile page.
Summary for 020639
Tradename:SEROQUEL
Applicant:Astrazeneca Pharms
Ingredient:quetiapine fumarate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020639
Medical Subject Heading (MeSH) Categories for 020639
Suppliers and Packaging for NDA: 020639
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SEROQUEL quetiapine fumarate TABLET;ORAL 020639 NDA AstraZeneca Pharmaceuticals LP 0310-0271 0310-0271-10 100 TABLET, FILM COATED in 1 BOTTLE (0310-0271-10)
SEROQUEL quetiapine fumarate TABLET;ORAL 020639 NDA AstraZeneca Pharmaceuticals LP 0310-0272 0310-0272-10 100 TABLET, FILM COATED in 1 BOTTLE (0310-0272-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 25MG BASE
Approval Date:Sep 26, 1997TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 100MG BASE
Approval Date:Sep 26, 1997TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 200MG BASE
Approval Date:Sep 26, 1997TE:ABRLD:Yes

Expired US Patents for NDA 020639

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca Pharms SEROQUEL quetiapine fumarate TABLET;ORAL 020639-001 Sep 26, 1997 ➤ Sign Up ➤ Sign Up
Astrazeneca Pharms SEROQUEL quetiapine fumarate TABLET;ORAL 020639-004 Dec 20, 1998 ➤ Sign Up ➤ Sign Up
Astrazeneca Pharms SEROQUEL quetiapine fumarate TABLET;ORAL 020639-003 Sep 26, 1997 ➤ Sign Up ➤ Sign Up
Astrazeneca Pharms SEROQUEL quetiapine fumarate TABLET;ORAL 020639-006 Oct 4, 2005 ➤ Sign Up ➤ Sign Up
Astrazeneca Pharms SEROQUEL quetiapine fumarate TABLET;ORAL 020639-005 Jul 26, 2000 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Citi
Healthtrust
Fuji
Mallinckrodt
Baxter
Federal Trade Commission
Covington
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.